Traditional clinical blood biomarkers of lung cancer include; neuron-specific enolase (NSE), progastrin-releasing peptide (pro-GRP), carcinoembryonic antigen (CEA), CYFRA 21-1, cancer antigen 15 (CA125) and squamous cell carcinoma antigen (SCC). This evidence concerns the gene GRP and lung carcinoma.